Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  Row (11) based on 13,953,018 shares of common stock outstanding as of April 27, 2026.


SCHEDULE 13G



 
Megan Greuling
 
Signature:/s/ Megan Greuling
Name/Title:Megan Greuling
Date:05/11/2026
 
Marion Brent Beason
 
Signature:/s/ Marion Brent Beason
Name/Title:Marion Brent Beason
Date:05/11/2026
 
Lebda Family Holdings, LLC
 
Signature:/s/ Richard Balot
Name/Title:Richard Balot, Manager
Date:05/11/2026
 
Estate of Douglas R. Lebda
 
Signature:/s/ Megan Greuling
Name/Title:Megan Greuling, co-executor
Date:05/11/2026
 
Signature:/s/ Marion Brent Beason
Name/Title:Marion Brent Beason, co-executor
Date:05/11/2026
 
Richard Balot
 
Signature:/s/ Richard Balot
Name/Title:Richard Balot
Date:05/11/2026
 
Steven D. Lockshin
 
Signature:/s/ Steven D. Lockshin
Name/Title:Steven D. Lockshin
Date:05/11/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

JOINT FILING AGREEMENT